Palm Beach Prostate Cancer Center is categorized under Implants, Surgical in Loxahatchee, FL and active since 1985.
Palm Beach Prostate Cancer Center was established in 1985, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Implants, Surgical business, which does work in the B2B market, and is classified as a Implants, Surgical, under code number 339113 by the NAICS.
If you are seeking more information, feel free to contact Edward Becker at the company’s single location by writing to 12953 Palms West Drive # 201, Loxahatchee, Florida FL 33470 or by phoning (561) 790-2111. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Palm Beach Prostate Cancer Center |
| Contact Person: | Edward Becker |
| Address: | 12953 Palms West Drive # 201, Loxahatchee, Florida 33470 |
| Phone Number: | (561) 790-2111 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1985 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Implants, Surgical |
| SIC Code: | 3842 |
| NAICS Code: | 339113 |
| Share This Business: |
Palm Beach Prostate Cancer Center was started in 1985 to provide professional Implants, Surgical under the SIC code 3842 and NAICS code 339113. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Edward Becker for inquiries that concern Palm Beach Prostate Cancer Center by calling the company number (561) 790-2111, as your correspondence is most welcome. Additionally, the physical location of the single location of Palm Beach Prostate Cancer Center can be found at the coordinates as well as the street address 12953 Palms West Drive # 201 in Loxahatchee, Florida 33470.
For its online presence, you may visit Palm Beach Prostate Cancer Center’s website at and engage with its social media outlets through on Twitter and on Facebook.